On March 19, 2024, Elicio Therapeutics, Inc closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.975 USD | -4.09% | +9.47% | +24.70% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.70% | 95.87M | |
+32.72% | 50.85B | |
+0.29% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.94% | 26.11B | |
-21.80% | 19.13B | |
+8.46% | 13.05B | |
+27.56% | 12.16B | |
+24.80% | 12.08B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $5.999999 million in funding from Gkcc, LLC